Isolation of Chlamydia trachomatis and membrane vesicles derived from host and bacteria.

[1]  V. Lupashin,et al.  Chlamydia trachomatis hijacks intra‐Golgi COG complex‐dependent vesicle trafficking pathway , 2012, Cellular microbiology.

[2]  B. Cookson,et al.  Membrane Vesicle Release in Bacteria, Eukaryotes, and Archaea: a Conserved yet Underappreciated Aspect of Microbial Life , 2012, Infection and Immunity.

[3]  G. Garrity.  Bergey’s Manual® of Systematic Bacteriology , 2012, Springer New York.

[4]  K. Brown,et al.  A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. , 2011, Vaccine.

[5]  G. Zhong,et al.  Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells. , 2011, Microbiology.

[6]  C. Elwell,et al.  Chlamydia trachomatis Co-opts GBF1 and CERT to Acquire Host Sphingomyelin for Distinct Roles during Intracellular Development , 2011, PLoS pathogens.

[7]  A. Subtil.  Rerouting of Host Lipids by Bacteria: Are You CERTain You Need a Vesicle? , 2011, PLoS pathogens.

[8]  M. Snape,et al.  A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease , 2011, Expert review of vaccines.

[9]  M. Kuehn,et al.  Immunization with Salmonella enterica Serovar Typhimurium-Derived Outer Membrane Vesicles Delivering the Pneumococcal Protein PspA Confers Protection against Challenge with Streptococcus pneumoniae , 2010, Infection and Immunity.

[10]  M. Kuehn,et al.  Biological functions and biogenesis of secreted bacterial outer membrane vesicles. , 2010, Annual review of microbiology.

[11]  Ding Chen,et al.  Characterization of Pgp3, a Chlamydia trachomatis Plasmid-Encoded Immunodominant Antigen , 2010, Journal of bacteriology.

[12]  P. Wyrick.  Chlamydia trachomatis persistence in vitro: an overview. , 2010, The Journal of infectious diseases.

[13]  A. Klos,et al.  Actin Re-Organization Induced by Chlamydia trachomatis Serovar D - Evidence for a Critical Role of the Effector Protein CT166 Targeting Rac , 2010, PloS one.

[14]  G. Myers,et al.  Strain and Virulence Diversity in the Mouse Pathogen Chlamydia muridarum , 2009, Infection and Immunity.

[15]  X. Rao,et al.  Mutagenesis of Region 4 of Sigma 28 from Chlamydia trachomatis Defines Determinants for Protein-Protein and Protein-DNA Interactions , 2008, Journal of bacteriology.

[16]  P. Wyrick,et al.  Trafficking of chlamydial antigens to the endoplasmic reticulum of infected epithelial cells. , 2008, Microbes and infection.

[17]  R. Valdivia,et al.  Reorganization of the host cytoskeleton by the intracellular pathogen Chlamydia trachomatis , 2008, Communicative & integrative biology.

[18]  Ding Chen,et al.  The Chlamydial Plasmid-Encoded Protein pgp3 Is Secreted into the Cytosol of Chlamydia-Infected Cells , 2008, Infection and Immunity.

[19]  E. Sugawara,et al.  Structural and Functional Analyses of the Major Outer Membrane Protein of Chlamydia trachomatis , 2007, Journal of bacteriology.

[20]  M. A. Pickett,et al.  The effect of penicillin on Chlamydia trachomatis DNA replication. , 2006, Microbiology.

[21]  J. Whittimore,et al.  Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. , 2006, Microbes and infection.

[22]  W. Beatty.  Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis , 2006, Journal of Cell Science.

[23]  Temple F. Smith,et al.  Identification of surface‐exposed components of MOMP of Chlamydia trachomatis serovar F , 2006, Protein science : a publication of the Protein Society.

[24]  W. Hennink,et al.  Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives. , 2005, Vaccine.

[25]  H. Caldwell,et al.  Comparative Genomic Analysis of Chlamydia trachomatis Oculotropic and Genitotropic Strains , 2005, Infection and Immunity.

[26]  M. Scidmore.  Cultivation and Laboratory Maintenance of Chlamydia trachomatis , 2005, Current protocols in microbiology.

[27]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[28]  T. Hackstadt,et al.  A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Timms,et al.  Chlamydial Persistence: beyond the Biphasic Paradigm , 2004, Infection and Immunity.

[30]  V. Herrera,et al.  Chlamydia pneumoniae Accelerates Coronary Artery Disease Progression in Transgenic Hyperlipidemia-Genetic Hypertension Rat Model , 2003, Molecular medicine.

[31]  T. Hackstadt,et al.  Chlamydia trachomatis Induces Remodeling of the Actin Cytoskeleton during Attachment and Entry into HeLa Cells , 2002, Infection and Immunity.

[32]  H. Gérard,et al.  Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. , 2002, Microbes and infection.

[33]  T. Hackstadt,et al.  The chlamydial inclusion: escape from the endocytic pathway. , 2002, Annual review of cell and developmental biology.

[34]  D. Crane,et al.  Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Criado,et al.  Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria. , 2001, Vaccine.

[36]  G. Zhong,et al.  Identification of a Chlamydial Protease–Like Activity Factor Responsible for the Degradation of Host Transcription Factors , 2001, The Journal of experimental medicine.

[37]  S. V. van IJzendoorn,et al.  Host cell‐derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis , 2000, Cellular microbiology.

[38]  R. Gottlieb,et al.  Nitrogen cavitation for cell disruption to obtain mitochondria from cultured cells. , 2000, Methods in enzymology.

[39]  H. Winkler,et al.  Two Nucleotide Transport Proteins in Chlamydia trachomatis, One for Net Nucleoside Triphosphate Uptake and the Other for Transport of Energy , 1999, Journal of bacteriology.

[40]  T. Michaelsen,et al.  Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response. , 1997, Vaccine.

[41]  J. Engel,et al.  Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells , 1997, Infection and immunity.

[42]  R. Heinzen,et al.  Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. , 1996, The EMBO journal.

[43]  T. Hatch.  Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae? , 1996, Journal of bacteriology.

[44]  T. Hackstadt,et al.  Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Beatty,et al.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. , 1994, Microbiological reviews.

[46]  A. F. Swanson,et al.  Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells , 1994, Infection and immunity.

[47]  J. Schachter,et al.  Culture and isolation of Chlamydia trachomatis. , 1994, Methods in enzymology.

[48]  J. Moulder.  Interaction of chlamydiae and host cells in vitro. , 1991, Microbiological reviews.

[49]  H. Caldwell,et al.  The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-specific epitopes , 1987, Infection and immunity.

[50]  T. Hatch,et al.  Adenine nucleotide and lysine transport in Chlamydia psittaci , 1982, Journal of bacteriology.

[51]  J. Moulder,et al.  Toxicity of Low and Moderate Multiplicities of Chlamydia psittaci for Mouse Fibroblasts (L Cells) , 1977, Infection and immunity.

[52]  G. Byrne,et al.  Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells) , 1976, Infection and immunity.

[53]  H. Winkler.  Rickettsial permeability. An ADP-ATP transport system. , 1976, The Journal of biological chemistry.

[54]  A. Matsumoto,et al.  Electron Microscopic Observations on the Structure of the Envelopes of Mature Elementary Bodies and Developmental Reticulate Forms of Chlamydia psittaci , 1971, Journal of bacteriology.

[55]  A. Matsumoto,et al.  Electron Microscopic Observations on the Effects of Penicillin on the Morphology of Chlamydia psittaci , 1970, Journal of bacteriology.